FADD Human shRNA Plasmid Kit (Locus ID 8772)
CAT#: TG320593
FADD - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
货期*
现货
规格
Cited in 1 publication. |
Product images
经常一起买 (2)
Anti-FADD mouse monoclonal antibody, clone OTI1C11 (formerly 1C11)
CNY 1,999.00
CNY 2,700.00
Specifications
Product Data | |
Product Name | FADD Human shRNA Plasmid Kit (Locus ID 8772) |
Locus ID | 8772 |
UniProt ID | Q13158 |
Synonyms | GIG3; MORT1 |
Vector | pGFP-V-RS |
Format | Retroviral plasmids |
Kit Components | FADD - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector(Gene ID = 8772). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pGFP-V-RS Vector, TR30013, included for free. |
RefSeq | NM_003824, NM_003824.1, NM_003824.3, BC000334, BC000334.2, BC025733, NM_003824.4 |
Summary | The protein encoded by this gene is an adaptor molecule that interacts with various cell surface receptors and mediates cell apoptotic signals. Through its C-terminal death domain, this protein can be recruited by TNFRSF6/Fas-receptor, tumor necrosis factor receptor, TNFRSF25, and TNFSF10/TRAIL-receptor, and thus it participates in the death signaling initiated by these receptors. Interaction of this protein with the receptors unmasks the N-terminal effector domain of this protein, which allows it to recruit caspase-8, and thereby activate the cysteine protease cascade. Knockout studies in mice also suggest the importance of this protein in early T cell development. [provided by RefSeq, Jul 2008] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (1)
The use of this RNAi has been cited in the following citations: |
---|
RIPK1 regulates survival of human melanoma cells upon endoplasmic reticulum stress through autophagy
,null,
Autophagy
,PubMed ID 26018731
[FADD]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...